Glial activation positron emission tomography imaging in radiation treatment of breast cancer brain metastases

Brain metastases affect more breast cancer patients than ever before due to increased overall patient survival with improved molecularly targeted treatments. Approximately 25–34% of breast cancer patients develop brain metastases in their lifetime. Due to the blood–brain barrier (BBB), the standard...

Descripción completa

Detalles Bibliográficos
Autores principales: Badiuk, Sawyer Rhae, Thiessen, Jonathan D., Maleki Vareki, Saman, Foster, Paula J., Chen, Jeff Z., Wong, Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961463/
https://www.ncbi.nlm.nih.gov/pubmed/35359488
http://dx.doi.org/10.1016/j.phro.2022.02.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961463/
https://www.ncbi.nlm.nih.gov/pubmed/35359488
http://dx.doi.org/10.1016/j.phro.2022.02.016

Ejemplares similares